CTCBIO Inc. (KOSDAQ:060590)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,890.00
-70.00 (-1.01%)
At close: Mar 28, 2025, 3:30 PM KST

CTCBIO Revenue

In the year 2024, CTCBIO had annual revenue of 144.41B KRW with 4.74% growth. CTCBIO had revenue of 40.60B in the quarter ending December 31, 2024, with 15.53% growth.

Revenue
144.41B
Revenue Growth
+4.74%
P/S Ratio
1.14
Revenue / Employee
579.95M
Employees
249
Market Cap
164.25B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024144.41B6.53B4.74%
Dec 31, 2023137.88B-27.33B-16.54%
Dec 31, 2022165.21B24.89B17.74%
Dec 31, 2021140.32B10.29B7.91%
Dec 31, 2020130.03B-6.09B-4.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 300.87T
SK hynix 66.19T
LG Energy Solution 25.62T
Samsung Biologics 4,547.32B
Hyundai Motor Company 175.23T
Kia Corporation 107.45T
Celltrion 3,557.30B
KB Financial Group 15.01T
Revenue Rankings